SE8403912D0 - PHARMACEUTICAL KIT OR COMPOSITION - Google Patents
PHARMACEUTICAL KIT OR COMPOSITIONInfo
- Publication number
- SE8403912D0 SE8403912D0 SE8403912A SE8403912A SE8403912D0 SE 8403912 D0 SE8403912 D0 SE 8403912D0 SE 8403912 A SE8403912 A SE 8403912A SE 8403912 A SE8403912 A SE 8403912A SE 8403912 D0 SE8403912 D0 SE 8403912D0
- Authority
- SE
- Sweden
- Prior art keywords
- physiologically acceptable
- composition
- pharmaceutical kit
- drug
- carrier
- Prior art date
Links
Abstract
A drug kit or drug composition for use in preventing and treating ischaemic cell damage comprises: a) at least one plasma volume expander; b) at least one low molecular, physiologically acceptable hydroxyl radical scavenger; c) at least one physiologically acceptable and water-soluble magnesium salt; and d) at least one organic compound active as a calcium blocking agent dissolved in a carrier, either per se or in one or several combinations.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8403912A SE8403912D0 (en) | 1984-07-30 | 1984-07-30 | PHARMACEUTICAL KIT OR COMPOSITION |
CA000487656A CA1246449A (en) | 1984-07-30 | 1985-07-29 | Drug kit or drug composition for ischaemic damage |
JP50341185A JPS61502821A (en) | 1984-07-30 | 1985-07-30 | drug kit or drug composition |
AU46713/85A AU4671385A (en) | 1984-07-30 | 1985-07-30 | A drug kit or drug composition |
EP19850903893 EP0188595A1 (en) | 1984-07-30 | 1985-07-30 | A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof |
PCT/SE1985/000296 WO1986000812A1 (en) | 1984-07-30 | 1985-07-30 | A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8403912A SE8403912D0 (en) | 1984-07-30 | 1984-07-30 | PHARMACEUTICAL KIT OR COMPOSITION |
Publications (1)
Publication Number | Publication Date |
---|---|
SE8403912D0 true SE8403912D0 (en) | 1984-07-30 |
Family
ID=20356627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8403912A SE8403912D0 (en) | 1984-07-30 | 1984-07-30 | PHARMACEUTICAL KIT OR COMPOSITION |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0188595A1 (en) |
JP (1) | JPS61502821A (en) |
AU (1) | AU4671385A (en) |
CA (1) | CA1246449A (en) |
SE (1) | SE8403912D0 (en) |
WO (1) | WO1986000812A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4939146A (en) * | 1987-01-29 | 1990-07-03 | Kramer Richard S | Method for alleviating ischemic-reperfusion injury |
ES2007994A6 (en) * | 1988-08-16 | 1989-07-01 | Grino Boira Jose Maria | Liquid medium for infusion and preservation of organs. |
CH683485A5 (en) * | 1990-11-20 | 1994-03-31 | Pasteur Merieux Serums Vacc | infusion solutions, preservation and organ perfusion. |
WO1994008612A1 (en) * | 1992-10-22 | 1994-04-28 | Thomas Peter G | New method of protecting central nervous system against damage resulting from cerebrovascular or neuronal compromise |
US6265385B1 (en) | 1996-01-11 | 2001-07-24 | Topo Target Aps | Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy |
WO1997025044A1 (en) * | 1996-01-11 | 1997-07-17 | Peter Buhl Jensen | Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy |
US5834178C1 (en) * | 1997-07-09 | 2002-04-23 | Univ Wayne State | Flush-storage solution for donor organs |
US6977140B1 (en) | 1998-09-29 | 2005-12-20 | Organ Recovery Systems, Inc. | Method for maintaining and/or restoring viability of organs |
DE69941362D1 (en) * | 1998-09-29 | 2009-10-15 | Organ Recovery Systems Inc | DEVICE AND METHOD FOR MAINTAINING AND / OR RESTORING THE VITABILITY OF ORGANS |
US6485959B1 (en) | 1998-10-07 | 2002-11-26 | Cedars Sinai Medical Center | Cell preconditioning and cryopresevation medium |
JP2001026536A (en) * | 1999-05-10 | 2001-01-30 | Nikken Kasei Kk | Radical scavenger |
US6492103B1 (en) | 2000-01-31 | 2002-12-10 | Organ Recovery Systems, Inc. | System for organ and tissue preservation and hypothermic blood substitution |
WO2007105179A1 (en) * | 2006-03-15 | 2007-09-20 | Universitat Bern | Cardioplegic solution |
PT2328593E (en) * | 2008-08-22 | 2015-04-13 | Universität Bern | Cardioplegic preparation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2532183C3 (en) * | 1975-07-18 | 1982-03-04 | Behringwerke Ag, 3550 Marburg | Polyionic isotonic saline solution for the preservation of erythrocytes or for the perfusion and preservation of organs intended for transplantation |
CH639270A5 (en) * | 1978-12-14 | 1983-11-15 | Koehler Franz Dr Chemie Kg | PROTECTIVE SOLUTION FOR HEART AND KIDNEY. |
FR2490963B1 (en) * | 1980-09-30 | 1986-04-18 | Science Union & Cie | NOVEL THERAPEUTIC COMPOSITION WITH ANTI-ISCHEMIC ACTION CONTAINING TRIMETHOXY 2, 3, 4-BENZYL 1-PIPERAZINE |
ATE11736T1 (en) * | 1980-12-23 | 1985-02-15 | Dr. Franz Koehler Chemie Gmbh | HEART AND KIDNEY PROTECTIVE SOLUTION AND PROCESS FOR PRODUCTION. |
SE8200252L (en) * | 1982-01-18 | 1983-07-19 | Pharmacia Ab | PHARMACEUTICAL COMPOSITION |
GB8308126D0 (en) * | 1983-03-24 | 1983-05-05 | Bloch M | Pharmaceutical compositions |
-
1984
- 1984-07-30 SE SE8403912A patent/SE8403912D0/en unknown
-
1985
- 1985-07-29 CA CA000487656A patent/CA1246449A/en not_active Expired
- 1985-07-30 AU AU46713/85A patent/AU4671385A/en not_active Abandoned
- 1985-07-30 WO PCT/SE1985/000296 patent/WO1986000812A1/en not_active Application Discontinuation
- 1985-07-30 EP EP19850903893 patent/EP0188595A1/en not_active Withdrawn
- 1985-07-30 JP JP50341185A patent/JPS61502821A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1986000812A1 (en) | 1986-02-13 |
CA1246449A (en) | 1988-12-13 |
AU4671385A (en) | 1986-02-25 |
JPS61502821A (en) | 1986-12-04 |
EP0188595A1 (en) | 1986-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8403912D0 (en) | PHARMACEUTICAL KIT OR COMPOSITION | |
ATE59297T1 (en) | TOPICAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITION CONTAINING A SILVER COMPOUND AND AN AZOLE. | |
ATE252081T1 (en) | NEW HIV PROTEASE INHIBITORS | |
NO20014662D0 (en) | Methods and Preparations for Treating Solid Tumors | |
ATE175412T1 (en) | HIV PROTEASE INHIBITORS | |
KR870005637A (en) | Drug depot | |
ATE311227T1 (en) | FAST-ACTING, FREEZE-DRIED, ORAL, PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF MIGRAINE | |
SE8504945L (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ANTRACYCLING GYCOSIDES | |
FI953748A (en) | Compounds with both potent calcium antagonist and antioxidant activity and their use as cell protective agents | |
UY26635A1 (en) | SYNERGIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
GR1001503B (en) | Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses. | |
DK0923570T3 (en) | Pyridylalkene and pyridylalkynic acid amides as cytostatic and immunosuppressive agents | |
BR0007589A (en) | Cell proliferation inhibitors | |
AR043071A1 (en) | USE OF MACROLIDES FOR THE TREATMENT OF CANCER AND MACULAR DEGENERATION AND A PHARMACEUTICAL COMPOSITION | |
ECSP930933A (en) | PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR PREPARING IT | |
DE69430385D1 (en) | HIV Protease Inhibitors | |
ATE201823T1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING HEPARIN | |
CA2361081A1 (en) | Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis | |
UY26514A1 (en) | "COMPOSITION FOR THE TREATMENT OF DAMAGED TISSUES". | |
GB9505082D0 (en) | Medicament | |
NZ336043A (en) | Use of COMT inhibitors for preventing diabetic vascular dysfunctions or neuropathy | |
WO1996000068A3 (en) | Combination therapy for hiv infection | |
IE840977L (en) | Pharmaceutical preparations | |
DE59510583D1 (en) | PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION WITH THE ACTIVE MORPHINE-6-GLUCURONIDE | |
BR0014751A (en) | Compound, stereoisomer or mixture of stereoisomers, pharmaceutical composition, method of treating a patient in need of antimicrobial treatment, and use of a compound |